Agent Capital is a healthcare venture fund focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs. The firm tapped Zer0 to 5ive for assistance in positioning and messaging and to…
For the past five years, Zer0 to 5ive has supported TrialScope with creative and public relations services. In April, the Company expanded Zer0 to 5ive’s role as part of its move to further increase market…
The CMU School of Computer Science (SCS) recently received the top national ranking for its AI specialty, which Zer0 to 5ive has helped promote over the past two years. As part of continuing to highlight…
Zer0 to 5ive recently launched a new co-brand and website for Pentra, an employee benefit consulting firm focused on improving the financial and operational performance of health care and employee benefit programs. The co-brand addresses…
Hoping to build on its award-winning ad campaign from 2016, which helped increase museum attendance substantially, the National Museum of Bermuda has once again selected Zer0 to 5ive to develop a new campaign targeted at…
Smart Meter, provider of the iGlucose Complete Diabetes Care Solution, recently retained Zer0 to 5ive to develop and implement its public relations and social media program, as part of its go-to-market strategy. The iGlucose solution…
After a successful launch of its new brand look and website, which Zer0 to 5ive completed in 20xx, LEM Capital has asked Zer0 to 5ive to further showcase its brand and success through a targeted…
After nearly two years of promoting Carnegie Mellon’s School of Computer Science with a focus on AI and Robotics, the School has expanded the engagement to include a focus on its excellence in Machine Learning,…
Argosy Capital has renewed its contract with Zer0 to 5ive for digital marketing, creative and web maintenance work in order to support the Argosy family of companies.
Zer0 to 5ive recently designed, built and launched a new website for Imagine Pharma, a drug discovery and development company that focuses on innovative approaches to therapeutic drugs for diabetes and cardiovascular disease.
